This webinar will provide an introduction to Design Systems and give some insight into why companies are taking up the challenge of developing a Design System.
Design Systems are not only a classification of components, but a whole process that is built and maintained by a company to help them develop superior user experiences and strengthen their brand.
The microbiome plays a crucial role in the regulation of human health. Major advances have been made in our understanding of the impact of the microbiome on drug metabolism and on a variety of diseases.
This webinar will provide an overview of the role of the microbiome with a specific focus on healthcare and will include real-life case studies covering oncology, and drug metabolism.
The Microbiome and Healthcare
Michael Zimmermann, Group Leader, EMBL
The Role of the Gut Microbiome in Tumour Growth and Response to Immunotherapy
Jackie Papkoff, CSO, Assembly Biosciences
Microbiome and Drug Metabolism With a Focus on Herbal Medicine
Manuela Pausan, Postdoc, Bayer
Panel Discussion
Manuela Pausan, Postdoc, Bayer
Jackie Papkoff, CSO, Assembly Biosciences
Michael Zimmermann, Group Leader, EMBL
Olaf Kelber, Principal Scientist Phytomedicines, Bayer
The Covid-19 pandemic has led to a step change in thinking on how research should be done. The challenges range from making labs safe for scientists, to accelerating the move towards virtualisation, digitalisation, and remote working. This webinar looks at what the Lab of the Future will look like post Covid with a special emphasis on technology, virtualisation, facilities, and workspace planning.
User research is grounded on a collaborative relationship with our end users – scientists, patients, healthcare providers, or other internal colleagues. But what about when you can’t physically be with research participants – be it because of cost, time, or global pandemic? Good news – research does not have to (and should not) stop! Remote research can often take the place of more standard face-to-face methods and glean similar user insights if properly used. And what you give up in physical presence can often be made up for in quantity and/or type of data.
This webinar sponsored by the Pistoia Alliance and the Quantum Economic Development Consortium (QED-C) focuses on the emerging opportunities at the convergence of Quantum Computing (QC) and pharmaceutical R&D. Leading experts provide an overview of QC and of the problems and bottlenecks in medicines discovery and development that may be addressed by advances in QC.
This webinar, supported by Thermo Fisher Scientific, outlines progress on the Pistoia Alliance Lab of the Future Projects and including updates on the Methods Database and the Universal Integration Layer.
It seems that AI is also becoming a buzzword, like design thinking. Everyone is talking about AI or wants to have AI, and sees all the ideas and benefits – that’s fine, but how do you get started? But what’s different now?
Three innovations have finally put AI on the fast track: Big Data, with the internet and sensors everywhere; massive computing power, especially through the Cloud; and the development of breakthrough algorithms, so computers can be trained to accomplish more sophisticated tasks on their own with deep learning.
If you use new technology, you need to explore and know what’s possible. With design thinking, it aids to outline the steps and define the ways in which you’re going to create the solution. Starting with mapping the customer journey, defining who will be using that service enhanced with intelligent technology, or who will benefit and gain value from it. We discuss how these two worlds are coming together, and how you get started to transform your venture with Artificial Intelligence using Design Thinking.
This article explores how digital technologies like AI, data analytics, and machine learning are set to transform life sciences and healthcare by 2030, improving drug development and personalised care, while also highlighting key challenges such as data privacy, regulation, and the need for cross-sector collaboration to realise these advancements effectively.
In this webinar our panel of UX specialists give a brief introduction to User Experience before presenting the design opportunities UX can bring to AI. We all know that AI has great potential but has some significant hurdles to overcome not least so the human aspect of trust and ethical considerations when designing in the life sciences.
Robert Roe discusses the role of Pistoia Alliance in creating the LOTF with Nick Lynch
The Pistoia Alliance developed a research paper which sets out to consider what the life science, biopharma R&D and healthcare ecosystem might look like in 2030
The Pistoia Alliance AbVance initiative was focused on two workstreams; (I) advancing the state of the art in antibody complex modelling for drug discovery, and (II) building better predictive models to address ‘developability’ risk
